Rifaximin Versus Lactulose in Renal Failure

Summary

The purpose of this study is to evaluate patients with cirrhosis of the liver and renal failure and determine if the administration of rifaximin as compared to lactulose is associated with less frequent and/or slower progression to severe hepatic encephalopathy. If one is associated with lower blood ammonia levels. And, if one is associated with lower breath hydrogen and methane levels.

Timeline

Start

2008-06

Primary completion

2009-07

Completion

2009-07

Drugs

Indications